Lin Jia

4.8k total citations · 1 hit paper
117 papers, 3.2k citations indexed

About

Lin Jia is a scholar working on Molecular Biology, Oncology and Cancer Research. According to data from OpenAlex, Lin Jia has authored 117 papers receiving a total of 3.2k indexed citations (citations by other indexed papers that have themselves been cited), including 62 papers in Molecular Biology, 33 papers in Oncology and 29 papers in Cancer Research. Recurrent topics in Lin Jia's work include Cancer-related molecular mechanisms research (15 papers), RNA modifications and cancer (12 papers) and Angiogenesis and VEGF in Cancer (10 papers). Lin Jia is often cited by papers focused on Cancer-related molecular mechanisms research (15 papers), RNA modifications and cancer (12 papers) and Angiogenesis and VEGF in Cancer (10 papers). Lin Jia collaborates with scholars based in China, United States and Hong Kong. Lin Jia's co-authors include Yan Fu, Andrew R. Hoffman, Ji‐Fan Hu, Jiuwei Cui, Naifei Chen, Lei Zhou, Shu-Man Jiang, Nan Song, Xin‐an Lu and Zhonghua Du and has published in prestigious journals such as Nucleic Acids Research, Nature Communications and SHILAP Revista de lepidopterología.

In The Last Decade

Lin Jia

113 papers receiving 3.2k citations

Hit Papers

Pembrolizumab monotherapy for previously untreated, PD-L1... 2018 2026 2020 2023 2018 100 200 300 400

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Lin Jia China 31 1.7k 1.1k 962 440 431 117 3.2k
Wenjuan Wang China 38 1.9k 1.1× 971 0.9× 778 0.8× 420 1.0× 326 0.8× 154 3.5k
Bríd M. Ryan United States 27 2.3k 1.3× 1.1k 1.0× 1.4k 1.5× 381 0.9× 495 1.1× 80 3.7k
Yuan Li China 32 2.4k 1.4× 649 0.6× 1.2k 1.3× 355 0.8× 427 1.0× 174 3.7k
Yan Zhou United States 33 1.6k 0.9× 754 0.7× 757 0.8× 703 1.6× 509 1.2× 122 3.3k
Jennifer L. Hsu United States 23 1.5k 0.9× 1.3k 1.2× 637 0.7× 471 1.1× 402 0.9× 55 3.2k
Qing Xiao China 26 2.0k 1.2× 572 0.5× 744 0.8× 316 0.7× 300 0.7× 87 3.7k
Yuan Zhang China 31 2.0k 1.2× 651 0.6× 1.1k 1.2× 563 1.3× 382 0.9× 178 3.5k
Wenjie Huang China 36 2.3k 1.3× 836 0.8× 1.2k 1.2× 610 1.4× 488 1.1× 176 3.8k

Countries citing papers authored by Lin Jia

Since Specialization
Citations

This map shows the geographic impact of Lin Jia's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Lin Jia with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Lin Jia more than expected).

Fields of papers citing papers by Lin Jia

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Lin Jia. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Lin Jia. The network helps show where Lin Jia may publish in the future.

Co-authorship network of co-authors of Lin Jia

This figure shows the co-authorship network connecting the top 25 collaborators of Lin Jia. A scholar is included among the top collaborators of Lin Jia based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Lin Jia. Lin Jia is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
2.
Sun, Jichao, Nayana Prabhu, Jun Tang, et al.. (2021). Recent advances in proteome‐wide label‐free target deconvolution for bioactive small molecules. Medicinal Research Reviews. 41(6). 2893–2926. 22 indexed citations
4.
Du, Zhonghua, Lin Jia, Yichen Wang, et al.. (2018). Combined RNA-seq and RAT-seq mapping of long noncoding RNAs in pluripotent reprogramming. Scientific Data. 5(1). 180255–180255. 13 indexed citations
6.
Adams, Sylvia, Sherene Loi, Deborah Toppmeyer, et al.. (2018). Pembrolizumab monotherapy for previously untreated, PD-L1-positive, metastatic triple-negative breast cancer: cohort B of the phase II KEYNOTE-086 study. Annals of Oncology. 30(3). 405–411. 460 indexed citations breakdown →
7.
Morgan, Stefanie L., Abel Bermudez, Nicole L. Arruda, et al.. (2017). Manipulation of nuclear architecture through CRISPR-mediated chromosomal looping. Nature Communications. 8(1). 15993–15993. 191 indexed citations
8.
Chen, Dongyun, et al.. (2016). Comparison of paroxetine and amitriptyline in the treatment of refractory globus pharyngeus. Digestive and Liver Disease. 48(9). 1012–1017. 10 indexed citations
9.
Wang, Shan, Xin‐an Lu, Peng Liu, et al.. (2015). Endostatin Has ATPase Activity, Which Mediates Its Antiangiogenic and Antitumor Activities. Molecular Cancer Therapeutics. 14(5). 1192–1201. 23 indexed citations
10.
Qi, Feifei, Ting He, Lin Jia, et al.. (2015). The miR-30 Family Inhibits Pulmonary Vascular Hyperpermeability in the Premetastatic Phase by Direct Targeting of Skp2. Clinical Cancer Research. 21(13). 3071–3080. 31 indexed citations
11.
12.
Yu, Xinfeng, et al.. (2014). Tag SNPs in complement receptor-1 contribute to the susceptibility to non-small cell lung cancer. Molecular Cancer. 13(1). 56–56. 15 indexed citations
13.
Li, Weidong, Lin Jia, Ya Ou, Yaoxing Huang, & Shu-Man Jiang. (2013). Surveillance of Intra-Abdominal Pressure and Intestinal Barrier Function in a Rat Model of Acute Necrotizing Pancreatitis and Its Potential Early Therapeutic Window. PLoS ONE. 8(11). e78975–e78975. 10 indexed citations
14.
Zhuo, Wei, Lin Jia, Nan Song, et al.. (2012). The CXCL12–CXCR4 Chemokine Pathway: A Novel Axis Regulates Lymphangiogenesis. Clinical Cancer Research. 18(19). 5387–5398. 95 indexed citations
15.
Huang, Yaoxing, Weidong Li, Lin Jia, et al.. (2012). Infliximab Enhances the Therapeutic Effectiveness of Octreotide on Acute Necrotizing Pancreatitis in Rat Model. Pancreas. 41(6). 849–854. 8 indexed citations
16.
Jiang, Shiqin, Jia Jia, Yuanyuan Shang, et al.. (2010). Selected Abstracts Submitted to the 2nd International Cancer Fatigue Symposium: Putting the Pieces Together. Current Oncology. 17(5). 78–83. 1 indexed citations
17.
Xie, Qi, et al.. (2009). Synergetic anticancer effect of combined gemcitabine and photodynamic therapy on pancreatic cancer in vivo. World Journal of Gastroenterology. 15(6). 737–737. 28 indexed citations
18.
Jia, Lin, Jianjun Zheng, Shineng Zhang, & De-Rong Xie. (2009). Gemcitabine arterial infusion chemotherapy versus intravenous chemotherapy for patients with advanced pancreatic cancer: a comparative study. 9(1). 15–17. 1 indexed citations
19.
Bai, Yu, Lin Jia, Huiqing Jiang, et al.. (2007). Severe Acute Pancreatitis in China. Pancreas. 35(3). 232–237. 72 indexed citations
20.
Jia, Lin. (2005). Comparison of probiotics and lactulose in the treatment of minimal hepatic encephalopathy in rats. World Journal of Gastroenterology. 11(6). 908–908. 40 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026